期刊文献+

他克莫司联合泼泥松片与恩替卡韦治疗合并乙型肝炎病毒感染的膜性肾小球肾炎疗效观察 被引量:2

Efficacy of Tacrolimus Combined with Prednisone Tablets and Enecavir in the Treatment of Membranous Glomerulonephritis Complicated with HBV Infection
下载PDF
导出
摘要 目的观察他克莫司联合泼尼松片与恩替卡伟治疗合并乙型肝炎病毒(HBV)感染的膜性肾小球肾炎的疗效。方法选择2015年3月—2018年3月南阳市第二人民医院收治的50例合并HBV感染的膜性肾小球肾炎患者,按照随机数字表法将患者分为对照组与观察组(各25例)。对照组患者采用泼尼松片[0.05mg(/kg·d)]和恩替卡伟(0.5mg/d)治疗,观察组患者采用他克莫司[0.05mg(/kg·d)]联合泼尼松片[0.05mg(/kg·d)]与恩替卡伟(0.5mg/d)治疗,比较两组患者的治疗疗效,治疗前后的尿蛋白定量、白蛋白、谷丙转氨酶、谷草转氨酶水平。结果观察组患者的治疗效果明显高于对照组,差异有统计学意义(P<0.05);治疗前,两组患者各指标比较无明显差异(P>0.05);治疗后,两组患者尿蛋白定量、谷丙转氨酶、谷草转氨酶显著降低,白蛋白明显升高(P<0.05);且观察组尿蛋白定量、谷丙转氨酶、谷草转氨酶均显著低于对照组,白蛋白明显高于对照组(P<0.05)。结论他克莫司联合泼尼松片与恩替卡伟治疗合并HBV感染的膜性肾小球肾炎效果更明显,能够保护肾脏功能,控制HBV的复制。 Objective To observe the efficacy of tacrolimus combined with prednisone tablets and enecavir in the treatment of membranous glomerulonephritis complicated with HBV infection. Methods 50 patients with membranous glomerulonephritis compli cated with HBV infection from March,2015 to March,2018were randomly divided into two groups:control group(n=25)and obser vation group(n=25). The patients in the control group were treated with prednisone tablets[0.05 mg(/ kg·d)]and enecavir(0.5 mg/ d),and the patients in the observation group were treated with tacrolimus[0.05 mg(/ kg·d)]combined with prednisone tablets[0.05 mg(/ kg·d)]and enecavir(0.5 mg/d)were used to compare the therapeutic efficacy,urinary protein quantity,albumin,glutamic pyruvic transaminase and glutamic oxaloacetic transaminase levels before and after treatment. Results The therapeutic effect of the pa tients in the observation group was significantly higher than that in the control group(P<0.05),but there was no significant differ ence between the two groups before treatment(P>0.05). After treatment,the urine protein quantity,glutamic pyruvic transaminase, glutamic oxaloacetic transaminase in the two groups decreased significantly and albumin increased significantly(P<0.05). The urine protein quantity,glutamic pyruvic transaminase,alanine aminotransferase in the observation group were significantly higher than the control group(P<0.05). Glutamic-oxaloacetic transaminase was significantly higher in the observation group than that in the control group(P<0.05). Conclusion Tacrolimus combined with prednisone tablets and enecavir are more effective in treating membranous glomerulonephritis complicated with HBV infection,which can protect renal function and control the replication of HBV.
作者 宋江庆 SONG Jiang-qing(Department of Pharmacy, Nanyang Second People’ s Hospital,Nanyang,Henan,473000,China)
出处 《黑龙江医学》 2019年第9期1102-1103,共2页 Heilongjiang Medical Journal
关键词 他克莫司 泼尼松片 HBV 性肾小球肾炎 Tacrolimus Prednisone tablets HBV Glomerulonephritis
  • 相关文献

参考文献4

二级参考文献36

  • 1马序竹,张宏,王素霞,邹万忠,王海燕.IgA肾病合并原发性膜性肾病二例并文献复习[J].中华内科杂志,2006,45(6):472-474. 被引量:14
  • 2杨林,段建召,王建荣,杨万霞.膜性肾病并发IgA肾病2例[J].河北医科大学学报,2006,27(5):448-449. 被引量:1
  • 3段建召,杨林,傅淑霞,王建荣,杨万霞.IgA肾病合并膜性肾病1例[J].临床与实验病理学杂志,2006,22(6):751-752. 被引量:2
  • 4王素霞,邹万忠,杨莉,赵明辉.膜性肾病合并IgA肾病的临床病理特点[J].中华病理学杂志,2007,36(3):171-174. 被引量:25
  • 5Trepo C, Chan HL, Lok A. Hepatitrs B virus infection [ J ] Lancet, 2014, 384(9959): 2053-2063.
  • 6Wang H, Fang M, Gu X, et al. The intracellular HBV DNAs as novel and sensitive biomarkers for the clinical diagnosis of occult HBV infection in HBeAg negative hepatocellular carcinomain China[J]. Plos One,2014, 9(9): e107162.
  • 7Wang H, Wang AH, Gressner OA, et al. Association between HBV Pre-S mutations and the intracellular HBV DNAs in HBsAg- positive hepatocellular carcinoma in China[ J ]. ClinExp Med,2014 Dec 11. [Epub ahead of print]. DOI 10. 1007/s10238-014-0321- 6.
  • 8European Association For The Study of The Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection[ J ]. J Hepatol, 2012,57 ( 1 ) : 167-185.
  • 9Shinkai N, Matsuura K, Sugauch F, et al. Application of a newly developed high-sensitivity HBsAg chemiluminescent enzyme immunoassay for hepatitis B patients with HBsAg seroclearance [ J ]. J ClinMicrobiol, 2013, 51 ( 11 ) : 1-8.
  • 10Liaw YF, Kao JH, Piratvisuth T, et al. Asian-Pacific consensus statement on the management of ehronichepatitis B : a 2012 update [J]. Hepatol Int, 2012, 6(3):531-561.

共引文献84

同被引文献16

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部